Standout Papers

Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment 2022 2026 2023 2024123
  1. Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment (2022)
    Moataz Reda, Worapol Ngamcherdtrakul et al. Nature Communications

Immediate Impact

2 by Nobel laureates 1 from Science/Nature 56 standout
Sub-graph 1 of 21

Citing Papers

Polymeric Nanoparticles for Drug Delivery
2024 Standout
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
2024 Standout
21 intermediate papers

Works of Moataz Reda being referenced

Targeted Nanoparticle for Co‐delivery of HER2 siRNA and a Taxane to Mirror the Standard Treatment of HER2+ Breast Cancer: Efficacy in Breast Tumor and Brain Metastasis
2022
PLK1 and EGFR targeted nanoparticle as a radiation sensitizer for non-small cell lung cancer
2019
and 5 more

Author Peers

Author Last Decade Papers Cites
Moataz Reda 383 265 167 223 20 728
Seungho Lim 383 433 107 262 18 827
Pengfei Zhao 332 215 163 193 21 770
Achuthamangalam B. Madhankumar 327 194 123 194 18 745
Hanhee Cho 303 370 218 282 26 724
L. Tiffany Lyle 372 195 171 182 21 801
Isaac M. Adjei 249 316 140 181 22 815
Ali Fotouhi 244 196 154 162 15 696
Wan Su Yun 229 384 125 216 25 664
Jiwoong Choi 260 460 208 249 23 760
Dennis Huang 231 433 127 287 14 711

All Works

Loading papers...

Rankless by CCL
2026